Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Total revenue $ 4,417 $ 15,134 $ 12,903 $ 18,354
Operating expenses:        
Research and development 21,365 21,127 42,862 42,447
General and administrative 6,566 8,922 14,186 17,151
Total operating expenses 27,931 30,049 57,048 59,598
Loss from operations 23,514 14,915 44,145 41,244
Interest and other income, net 186 81 256 133
Interest and other expense, net (1,092) (767) (2,142) (1,268)
Net loss 24,420 15,601 46,031 42,379
Net loss attributable to common shareholders $ 24,420 $ 15,601 $ 46,031 $ 42,379
Net loss per share attributable to common shareholders:        
Basic $ 0.43 $ 0.28 $ 0.82 $ 0.78
Diluted $ 0.43 $ 0.28 $ 0.82 $ 0.78
Weighted average number of shares used in net loss per share calculations:        
Basic 56,329,585 56,096,238 56,317,384 54,340,173
Diluted 56,329,585 56,096,238 56,317,384 54,340,173
Research And Development Revenue, Related Party        
Total revenue $ 0 $ 12,899 $ 0 $ 13,136
Research And Development Revenue, Other        
Total revenue $ 4,417 $ 2,235 $ 12,903 $ 5,218